-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Monday's Pre-Market Session
Share
Listen to the news

Gainers

  • Advanced Biomed (NASDAQ:ADVB) shares rose 24.1% to $6.24 during Monday's pre-market session. The market value of their outstanding shares is at $8.2 million.
  • Barinthus Biotherapeutics (NASDAQ:BRNS) shares rose 10.17% to $0.61. The market value of their outstanding shares is at $22.6 million.
  • HCW Biologics (NASDAQ:HCWB) shares rose 10.0% to $4.4. The company's market cap stands at $6.3 million.
  • Camp4 Therapeutics (NASDAQ:CAMP) stock rose 9.97% to $4.08. The market value of their outstanding shares is at $192.6 million.
  • Atara Biotherapeutics (NASDAQ:ATRA) shares rose 7.27% to $9.0. The company's market cap stands at $75.5 million.
  • Genenta Science (NASDAQ:GNTA) stock increased by 7.09% to $1.66. The market value of their outstanding shares is at $36.3 million.

Losers

  • BioVie (NASDAQ:BIVI) shares decreased by 15.6% to $1.52 during Monday's pre-market session. The market value of their outstanding shares is at $13.5 million.
  • GlucoTrack (NASDAQ:GCTK) shares declined by 13.4% to $0.43. The company's market cap stands at $3.2 million.
  • Bluejay Diagnostics (NASDAQ:BJDX) stock decreased by 11.04% to $1.29. The company's market cap stands at $1.5 million.
  • Valion Bio (NASDAQ:VBIO) shares decreased by 10.94% to $0.45. The market value of their outstanding shares is at $1.6 million.
  • Elutia (NASDAQ:ELUT) shares fell 9.48% to $0.86. The market value of their outstanding shares is at $41.9 million.
  • GRI Bio (NASDAQ:GRI) shares fell 9.34% to $1.36. The company's market cap stands at $2.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending